company background image
APN logo

Aspen Pharmacare Holdings JSE:APN 株式レポート

最終価格

R170.07

時価総額

R75.5b

7D

-0.6%

1Y

-5.7%

更新

24 Nov, 2024

データ

会社財務 +

Aspen Pharmacare Holdings Limited

JSE:APN 株式レポート

時価総額:R75.5b

APN 株式概要

アスペン・ファーマケア・ホールディングス・リミテッドはその子会社とともに、世界中で特殊医薬品およびブランド医薬品を製造・供給している。 詳細

APN ファンダメンタル分析
スノーフレーク・スコア
評価3/6
将来の成長4/6
過去の実績1/6
財務の健全性5/6
配当金2/6

Aspen Pharmacare Holdings Limited 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめAspen Pharmacare Holdings
過去の株価
現在の株価R170.07
52週高値R252.96
52週安値R168.50
ベータ0.58
11ヶ月の変化-5.77%
3ヶ月変化-25.97%
1年変化-5.68%
33年間の変化-19.91%
5年間の変化44.86%
IPOからの変化19,127.38%

最新ニュース

Recent updates

Aspen Pharmacare Holdings Limited (JSE:APN) Not Lagging Market On Growth Or Pricing

Nov 09
Aspen Pharmacare Holdings Limited (JSE:APN) Not Lagging Market On Growth Or Pricing

Aspen Pharmacare Holdings' (JSE:APN) Conservative Accounting Might Explain Soft Earnings

Oct 10
Aspen Pharmacare Holdings' (JSE:APN) Conservative Accounting Might Explain Soft Earnings

Here's Why Aspen Pharmacare Holdings (JSE:APN) Has A Meaningful Debt Burden

Oct 01
Here's Why Aspen Pharmacare Holdings (JSE:APN) Has A Meaningful Debt Burden

Aspen Pharmacare Holdings (JSE:APN) Has Announced That It Will Be Increasing Its Dividend To ZAR3.59

Sep 10
Aspen Pharmacare Holdings (JSE:APN) Has Announced That It Will Be Increasing Its Dividend To ZAR3.59

We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt

May 08
We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt

Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable

Mar 05
Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable

Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Dec 22
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Dec 01
Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Mar 31
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case

Jan 11
With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case

These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well

Oct 22
These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well

We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease

Oct 06
We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease

Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's

Sep 21
Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's

Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially

Sep 08
Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially

Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26

Sep 07
Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26

Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today

Jun 15
Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today

Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly

Apr 02
Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting

Mar 16
With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting

An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued

Mar 02
An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued

Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?

Dec 23
Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?

Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation

Dec 02
Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation

We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative

Oct 11
We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative

After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar

Sep 30
After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar

Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump

Sep 30
Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump

株主還元

APNZA PharmaceuticalsZA 市場
7D-0.6%-0.7%2.2%
1Y-5.7%-1.9%13.9%

業界別リターン: APN過去 1 年間で-1.9 % の収益を上げたZA Pharmaceuticals業界を下回りました。

リターン対市場: APNは、過去 1 年間で13.9 % のリターンを上げたZA市場を下回りました。

価格変動

Is APN's price volatile compared to industry and market?
APN volatility
APN Average Weekly Movement4.4%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement4.4%
10% most volatile stocks in ZA Market9.3%
10% least volatile stocks in ZA Market2.6%

安定した株価: APN過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: APNの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
18509,109Stephen Saadwww.aspenpharma.com

アスペン・ファーマケア・ホールディングス・リミテッドはその子会社とともに、世界中で特殊医薬品とブランド医薬品を製造・供給している。業務用医薬品事業と製造事業を行っている。ディプリバン、エムラ、フラクシパリン、マーカイン、ウルティバ、キシロカインのブランド名で、全身麻酔薬、局所麻酔薬、低分子ヘパリン、局所麻酔薬、脊椎麻酔薬、オピオイド鎮痛薬を提供している。また、Circadin、Eltroxin、Foxair、Imuran、Maltofer、Mybulen、Ovestinのブランド名で、睡眠導入剤、甲状腺ホルモン剤、免疫抑制剤、鉄剤、鎮痛消炎剤、ホルモン補充療法なども提供している。また、原薬や完成品の製造・販売も行っている。アスペン・ファーマケア・ホールディングス・リミテッドは1850年に設立され、南アフリカのダーバンに本社を置いている。

Aspen Pharmacare Holdings Limited 基礎のまとめ

Aspen Pharmacare Holdings の収益と売上を時価総額と比較するとどうか。
APN 基礎統計学
時価総額R75.55b
収益(TTM)R4.40b
売上高(TTM)R44.71b

17.2x

PER(株価収益率

1.7x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
APN 損益計算書(TTM)
収益R44.71b
売上原価R25.29b
売上総利益R19.42b
その他の費用R15.01b
収益R4.40b

直近の収益報告

Jun 30, 2024

次回決算日

該当なし

一株当たり利益(EPS)9.91
グロス・マージン43.43%
純利益率9.85%
有利子負債/自己資本比率42.3%

APN の長期的なパフォーマンスは?

過去の実績と比較を見る

配当金

2.1%

現在の配当利回り

36%

配当性向